Cleared Traditional

K802164 - 8-HYDROXYQUINOLINE

K802164 is the FDA 510(k) clearance for 8-HYDROXYQUINOLINE by Panmed, Inc.. It is a Class 2 Chemistry device (product code CIC) cleared through the Traditional 510(k) pathway after a 32-day FDA review.

K802164 · Panmed, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1980
Decision
32d
Days
Class 2
Risk

K802164 is an FDA 510(k) clearance for the 8-HYDROXYQUINOLINE, CRESOLPHTHALEIN COM.. Classified as Cresolphthalein Complexone, Calcium (product code CIC), Class II - Special Controls.

Submitted by Panmed, Inc. (Mchenry, US). The FDA issued a Cleared decision on October 10, 1980 after a review of 32 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1145 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Panmed, Inc. devices

Submission Details

510(k) Number K802164 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 1980
Decision Date October 10, 1980
Days to Decision 32 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 88d · This submission: 32d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIC Cresolphthalein Complexone, Calcium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1145
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIC Cresolphthalein Complexone, Calcium

All 69
Devices cleared under the same product code (CIC) and FDA review panel - the closest regulatory comparables to K802164.
GILCHEM CALCIUM REAGENT
K812110 · Gilford Diagnostics · Aug 1981
KING DIAGNOSTICS CALCIUM TEST
K811748 · King Diagnostics, Inc. · Jul 1981
BECKMAN ASTRA SYSTEMS CALCIUM CHEMISTRY
K802923 · Beckman Instruments, Inc. · Dec 1980
CALCIUM REAGENT SYSTEM NO. 585
K780983 · Sigma Chemical Co. · Jul 1978
CALCIUM REAGENT
K771310 · Mallinckrodt Critical Care · Aug 1977
CENTRIFI CHEM CALCIUM REAGENT
K770460 · Union Carbide Corp. · Jun 1977